Guobin Zhang

Guobin Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2020 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
JLJun Liu
Jun Liu
ZZZhengkun Zhu
Zhengkun Zhu
LWLeibo Wang
Leibo Wang
JDJixiang Du
Jixiang Du
BZBiao Zhang
Biao Zhang
GZGuobin Zhang
Guobin Zhang

30 April 2024 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
JLJun Liu
Jun Liu
SZShusheng Zhang
Shusheng Zhang
YCYueda Chen
Yueda Chen
XJXiaoxiong Jia
Xiaoxiong Jia
ZLZhongzhen Li
Zhongzhen Li
Rongcai JiangRongcai Jiang
Rongcai Jiang

28 November 2025 in Science Advances
Verified
Journal Article
Open access
JFJiayuanyuan Fu
Jiayuanyuan Fu
JWJingheng Wu
Jingheng Wu
MDMengran Du
Mengran Du
XWXu Wang
Xu Wang
QSQi Shi
Qi Shi
HYHua Yan
Hua Yan
Brain-kidney cross-talk following traumatic brain injury (TBI) can induce acute kidney injury (AKI), but mechanisms remain unclear. Extracellular vesicles derived from injured brain tissue (TBI-EVs) may mediate brain-kidney interactions. In vivo experiments demonstrated that TBI-EVs causes AKI by promoting pro-inflammatory macrophage polarization. TBI-EVs markedly increased AKI markers and proportion of pro-inflammatory-polarized macrophages. Mechanistically, transcriptomics of TBI-EVs revealed high circUsp32 expression. Subsequent in vitro assays showed that circUsp32 competitively binds to the SH2 domain of suppressor of cytokine signaling 1 (Socs1), affecting interferon regulator factor 7 (IRF7) ubiquitination and promoting pro-inflammatory polarization. CircUsp32 knockdown reduced pro-inflammatory polarization and alleviated AKI in TBI mice. In addition, circUsp32 is homologous to hsa_circ_0044940, which may serve as a predicted biomarker of AKI after TBI. Notably, AKI following TBI may contribute to neuroinflammation via uremic toxins. Collectively, these findings suggest that circUsp32 mediates macrophage polarization through the Socs1/IRF7 axis and could be a potential biomarker for AKI following TBI.

27 March 2024 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
SZShusheng Zhang
Shusheng Zhang
YCYanan Chen
Yanan Chen
XWXiudong Wang
Xiudong Wang
JLJun Liu
Jun Liu
YCYueda Chen
Yueda Chen
GZGuobin Zhang
Guobin Zhang

30 October 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TLTuo Li
Tuo Li
DWDianyi Wang
Dianyi Wang
LLLei Li
Lei Li
HHHongying Hao
Hongying Hao
CWCong Wang
Cong Wang
HWHongguang Wang
Hongguang Wang
Traumatic brain injury (TBI) triggers a secondary injury cascade characterized by neuroinflammation, blood-brain barrier disruption, cerebral hypoperfusion, and progressive neuronal loss, yet effective therapies remain limited. Here, we investigated whether kaempferol attenuates secondary brain injury after TBI in mice by suppressing neuroinflammation. Using a fluid percussion injury model, we performed transcriptomic, histological, behavioral, cerebral perfusion, flow cytometric, and protein analyses. Kaempferol treatment reduced lesion burden, tissue disruption, and Evans blue extravasation, and improved neurological, motor, and cognitive outcomes after TBI. It also decreased neuronal loss and neuronal apoptosis in the injured cortex and hippocampus. Notably, kaempferol reduced microglial accumulation and neutrophil infiltration and was associated with a less pro-inflammatory microglial cytokine profile, including reduced IL-1β and TNF-α expression and increased IL-4 and TGF-β expression. And in vitro, kaempferol attenuated LPS-induced pro-inflammatory activation of BV2 microglial cells. In addition, kaempferol increased CD31 immunoreactivity, restored ZO-1 immunoreactivity along CD31-positive microvessels, improved ipsilateral cortical blood flow, and was accompanied by increased expression of PI3K, p-AKT, HIF-1α, VEGF, HO-1, and Bcl-2, together with reduced Bax and cleaved caspase-3. These findings indicate that kaempferol attenuates secondary brain injury after TBI in mice, with reduced neuroinflammation, oxidative stress, BBB disruption, vascular dysfunction, and neuronal apoptosis as prominent associated features.

1 April 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GZGuobin Zhang
Guobin Zhang
ZJZhi-Jiao Jia
Zhi-Jiao Jia
MZMing-Hao Zhang
Ming-Hao Zhang
YLYu-Jie Li
Yu-Jie Li
LTLuan-Yuan Tian
Luan-Yuan Tian
JCJing Cheng
Jing Cheng